# Inspire Medical (INSP) — Earnings

INSP · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/insp/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.14 |
| EPS estimate | −$0.24 |
| EPS surprise | +159.35% |
| Revenue surprise | +3.01% |
| Revenue | $200.6M |
| Revenue estimate | $194.7M |
| Reported | Aug 3, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1609550/000160955026000047/insp-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/1fd6e0cb-90bb-ff5a-812c-7fae00ec8107.html) |

Inspire Medical reported Q2 2026 results on August 3, 2026. Earnings per share were $0.14, a profit against an expected loss of $0.24, a beat of 159.35%. Revenue was $200.6 million, above the $194.7 million estimate. Compared with Q2 2025, though, EPS fell about 69% from $0.45 and revenue fell 7.6% from $217.1 million.

Over the longer record the company moved from losses to profits. Annual EPS went from a $1.64 loss in 2022 and a $0.74 loss in 2023 to profits of $1.73 in 2024 and $2.58 in 2025. Revenue grew each year, from $407.9 million in 2022 to $912.0 million in 2025, up 13.6% in the latest year. Q4 is the largest quarter of each year in the table, and Q4 2025 set the highs here at $1.65 per share and $269.1 million in revenue. The first half of 2026 brought $405.2 million of revenue, 3.2% less than a year earlier, and EPS of $0.24 against $0.55. Inspire beat the EPS estimate in all 20 quarters shown.

Third-quarter results have come out in early November in each of the past five years. That points to early November 2026 for the next report.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 3, 2026 | −$0.24 | $0.14 | 159.35% | $194.7M | $200.6M |
| Q1 2026 | May 4, 2026 | −$0.28 | $0.10 | 136.32% | $200.0M | $204.6M |
| Q4 2025 | Feb 11, 2026 | $0.68 | $1.65 | 143.87% | $265.3M | $269.1M |
| Q3 2025 | Nov 3, 2025 | −$0.19 | $0.38 | 300.63% | $220.4M | $224.5M |
| Q2 2025 | Aug 4, 2025 | $0.20 | $0.45 | 122.88% | $214.3M | $217.1M |
| Q1 2025 | May 5, 2025 | −$0.25 | $0.10 | 140.32% | $195.2M | $201.3M |
| Q4 2024 | Feb 10, 2025 | $0.73 | $1.15 | 57.21% | $236.8M | $239.7M |
| Q3 2024 | Nov 4, 2024 | $0.06 | $0.60 | 875.61% | $197.6M | $203.2M |
| Q2 2024 | Aug 6, 2024 | −$0.14 | $0.32 | 328.90% | $189.1M | $195.9M |
| Q1 2024 | May 7, 2024 | −$0.65 | −$0.34 | 47.80% | $161.4M | $164.0M |
| Q4 2023 | Feb 6, 2024 | −$0.05 | $0.49 | 1015.89% | $186.7M | $192.5M |
| Q3 2023 | Nov 7, 2023 | −$0.58 | −$0.29 | 50.00% | $154.5M | $153.3M |
| Q2 2023 | Aug 1, 2023 | −$0.57 | −$0.41 | 28.01% | $136.5M | $151.1M |
| Q1 2023 | May 2, 2023 | −$0.66 | −$0.53 | 19.73% | $120.1M | $127.9M |
| Q4 2022 | Feb 7, 2023 | −$0.61 | $0.10 | 116.48% | $131.1M | $137.9M |
| Q3 2022 | Nov 1, 2022 | −$0.76 | −$0.60 | 20.59% | $94.3M | $109.2M |
| Q2 2022 | Aug 2, 2022 | −$0.61 | −$0.53 | 12.94% | $78.5M | $91.4M |
| Q1 2022 | May 3, 2022 | −$0.80 | −$0.61 | 23.37% | $64.2M | $69.4M |
| Q4 2021 | Feb 8, 2022 | −$0.44 | −$0.09 | 79.42% | $74.6M | $78.4M |
| Q3 2021 | Nov 2, 2021 | −$0.61 | −$0.38 | 38.16% | $55.6M | $61.7M |

## Frequently Asked Questions

### When did Inspire Medical (INSP) last report earnings?

Inspire Medical last reported on Aug 3, 2026, covering fiscal Q2 2026.

### Did INSP beat earnings estimates?

Yes. Inspire Medical reported EPS of $0.14 for Q2 2026 against a −$0.24 estimate — a 159.35% beat.

### How much revenue did INSP report last quarter?

Inspire Medical reported $200.6M in revenue for Q2 2026, against a consensus estimate of $194.7M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).